Literature DB >> 16254328

NS1 protein secretion during the acute phase of West Nile virus infection.

Joanne Macdonald1, Jessica Tonry, Roy A Hall, Brent Williams, Gustavo Palacios, Mundrigi S Ashok, Omar Jabado, David Clark, Robert B Tesh, Thomas Briese, W Ian Lipkin.   

Abstract

The West Nile virus (WNV) nonstructural protein NS1 is a protein of unknown function that is found within, associated with, and secreted from infected cells. We systematically investigated the kinetics of NS1 secretion in vitro and in vivo to determine the potential use of this protein as a diagnostic marker and to analyze NS1 secretion in relation to the infection cycle. A sensitive antigen capture enzyme-linked immunosorbent assay (ELISA) for detection of WNV NS1 (polyclonal-ACE) was developed, as well as a capture ELISA for the specific detection of NS1 multimers (4G4-ACE). The 4G4-ACE detected native NS1 antigens at high sensitivity, whereas the polyclonal-ACE had a higher specificity for recombinant forms of the protein. Applying these assays we found that only a small fraction of intracellular NS1 is secreted and that secretion of NS1 in tissue culture is delayed compared to the release of virus particles. In experimentally infected hamsters, NS1 was detected in the serum between days 3 and 8 postinfection, peaking on day 5, the day prior to the onset of clinical disease; immunoglobulin M (IgM) antibodies were detected at low levels on day 5 postinfection. Although real-time PCR gave the earliest indication of infection (day 1), the diagnostic performance of the 4G4-ACE was comparable to that of real-time PCR during the time period when NS1 was secreted. Moreover, the 4G4-ACE was found to be superior in performance to both the IgM and plaque assays during this time period, suggesting that NS1 is a viable early diagnostic marker of WNV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254328      PMCID: PMC1280181          DOI: 10.1128/JVI.79.22.13924-13933.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Identification and analysis of truncated and elongated species of the flavivirus NS1 protein.

Authors:  B J Blitvich; D Scanlon; B J Shiell; J S Mackenzie; R A Hall
Journal:  Virus Res       Date:  1999-03       Impact factor: 3.303

2.  West Nile, Ilheus, and Bunyamwera virus infections in man.

Authors:  C M SOUTHAM; A E MOORE
Journal:  Am J Trop Med Hyg       Date:  1951-11       Impact factor: 2.345

3.  A novel complex formed between the flavivirus E and NS1 proteins: analysis of its structure and function.

Authors:  B J Blitvich; J S Mackenzie; R J Coelen; M J Howard; R A Hall
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication.

Authors:  J M Mackenzie; M K Jones; P R Young
Journal:  Virology       Date:  1996-06-01       Impact factor: 3.616

5.  trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication.

Authors:  B D Lindenbach; C M Rice
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation.

Authors:  I R Muylaert; R Galler; C M Rice
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures.

Authors:  E G Westaway; J M Mackenzie; M T Kenney; M K Jones; A A Khromykh
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Expression and purification of the seven nonstructural proteins of the flavivirus Kunjin in the E. coli and the baculovirus expression systems.

Authors:  A A Khromykh; T J Harvey; M Abedinia; E G Westaway
Journal:  J Virol Methods       Date:  1996-09       Impact factor: 2.014

9.  Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion.

Authors:  M Flamand; F Megret; M Mathieu; J Lepault; F A Rey; V Deubel
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

10.  Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function.

Authors:  B D Lindenbach; C M Rice
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

View more
  50 in total

1.  The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex.

Authors:  Leah K Gillespie; Antje Hoenen; Gary Morgan; Jason M Mackenzie
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition.

Authors:  Soonjeon Youn; Hyelim Cho; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Flavivirus nonstructural protein NS1: complementary surprises.

Authors:  Jacob J Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-04       Impact factor: 11.205

4.  West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H.

Authors:  Kyung Min Chung; M Kathryn Liszewski; Grant Nybakken; Alan E Davis; R Reid Townsend; Daved H Fremont; John P Atkinson; Michael S Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-28       Impact factor: 11.205

Review 5.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release.

Authors:  A Sami Saribas; Martyn K White; Mahmut Safak
Journal:  J Cell Physiol       Date:  2017-08-28       Impact factor: 6.384

7.  Identification of novel small-molecule inhibitors of West Nile virus infection.

Authors:  Amine O Noueiry; Paul D Olivo; Urszula Slomczynska; Yi Zhou; Ben Buscher; Brian Geiss; Michael Engle; Robert M Roth; Kyung Min Chung; Melanie Samuel; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

8.  The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles.

Authors:  Scott R Schaecher; Jason M Mackenzie; Andrew Pekosz
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction.

Authors:  Jason R Wilson; Paola Florez de Sessions; Megan A Leon; Frank Scholle
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice.

Authors:  Kyung Min Chung; Michael S Diamond
Journal:  J Med Virol       Date:  2008-03       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.